No Data
No Data
CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Why CG Oncology (CGON) Is the Most Oversold Healthcare Stock to Buy Now
BofA Securities Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $65
CG Oncology, Inc. (NASDAQ:CGON) Is a Favorite Amongst Institutional Investors Who Own 62%
Does CG Oncology, Inc. (CGON) Have the Potential to Rally 123.34% as Wall Street Analysts Expect?
CG Oncology Amends Key Executive Employment Agreements